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Volume 46, Number 3 Armstrong et al 465and reconfirm the severity of contralateral disease. If DUS
testing confirms 50% ICA stenosis bilateral beyond the
first 18 months, an annual scan is adequate for disease
monitoring. Surveillance every 6 months is recommended
in patients with 50% DR ipsilateral or contralateral ICA
stenosis. The development of hemispheric symptoms in the
presence of50% DR ICA or CAS stenosis, or asymptom-
atic disease progression to a high-grade stenosis (75% to
80% DR, EDV 140 cm/s), should prompt a recommen-
dation of surgical or endovascular (stent-assisted angio-
plasty) intervention in appropriate patients.
CONCLUSION
DUS surveillance after CAS identified a 5% procedural
failure rate due to the development of high-grade in-stent
stenosis, a higher clinical yield than CEA surveillance. Both
progression and regression of stent stenosis severity was
observed on serial testing, but 70% of CAS sites demon-
strated velocity spectra consistent with 50% DR. Con-
tralateral disease progression remains a risk factor, with a 5%
intervention rate after both CEA and CAS using similar
velocity spectra criteria indicating 75% DR stenosis. Our
policy of DUS surveillance and reintervention for high-
grade stenosis was associated with sustained stent patency
and infrequent neurologic events.
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Dr Ali F. AbuRahma (Charleston, WV). Carotid artery
stenting has become an accepted treatment modality for carotid
stenosis, particularly in high-risk patients. However, there is an
ongoing debate regarding which duplex ultrasound criteria to use
to determine the rate of in-stent restenosis. This study is by Dr
Armstrong and his group, and they are well respected and nation-
ally known for their advocacy for duplex scan surveillance after
vascular interventions. This study reports on duplex scan surveil-
lance after carotid artery stenting and the rationale for the defini-
tion of in-stent restenosis.
In this study, Dr Armstrong and his group analyzed their
experience using a previously validated surveillance protocol after
carotid endarterectomy and applied these criteria to carotid artery
stenting surveillance. In a similar study that we presented at the
Eastern Vascular Society meeting in Washington, DC in Septem-
ber 2006, which is presently in press, when we applied the old
duplex ultrasound velocity criteria for nonstented carotid arteries,nosis, as defined by a peak systolic velocity of 120 cm/s, how-
ever, when we applied new duplex ultrasound criteria for stented
arteries, a peak systolic velocity of155 cm/s was consistent with
30% restenosis in only 33% of patients at a mean follow-up of 2
years.
With this in mind, I have the following questions and/or
comments for Dr. Armstrong.
First, it is noted in your study that you used criteria for carotid
artery stent surveillance that was somewhat similar with some
modification to the criteria your group published in the Journal of
Vascular Surgery in 1999 for carotid endarterectomy surveillance.
Specifically, to define a 50% stenosis category, the peak systolic
velocity was increased from 125 cm/s to 150 cm/s, with an
ICA/CCA ratio of 2; and for 50% to 75% stenosis, the peak
systolic velocity was raised from 125 cm/s to 150 cm/sec, with
a ratio of 2. For stenosis75%, the criteria were left the same (eg,
a peak systolic velocity of300 cm/s with a ratio of4 and an end
diastolic velocity 125 cm/s. Did you validate these criteria on
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obtain any other modality, specifically, carotid angiography or
CTA, to verify the degree of in-stent restenosis? If so, did you
conduct any ROC curves to detect the sensitivity, specificity,
positive and negative predictive values for specific velocities that
were consistent with the various classifications you propose in your
study?
Second, did you obtain immediate duplex ultrasounds after
completion of the carotid stenting to compare normal angiography
after carotid stenting to the peak systolic velocities and/or the end
diastolic velocities?
Third, in your presentation, only six patients were found to
have 75% in-stent restenosis that required intervention. In view
of the earlier discussion, is it possible that there are other patients
who have similar stenoses that were missed because of your present
criteria? It is my understanding that these are the only six patients
who had their stenoses confirmed by arteriography.
I enjoyed your presentation, and I am looking forward to
seeing additional work on this very important clinical subject from
your well-respected institution.Dr Paul A. Armstrong: Certainly one criticism of this review
may be the lack of a structured validation method (ie, angiogra-
phy), but the validation for carotid duplex criteria does have an
established track record, including recent work done by Dr Hob-
son and others. We believe these data to be valid based on the
recent information provided by the core duplex reading center
from the CREST Trial, which documented strongly favorable
positive predictive values for defining moderate and high-grade
lesions using similar duplex criteria.
Our current surveillance protocol includes immediate duplex
scanning the day of the procedure. In addition we are now using
IVUS as part of stent implantation to provide in formation on
vessel diameters, plaque morphology, and stent apposition.
In answer to whether or not we aremissing high-grade lesions,
we would say no. As you are aware, some investigators are support-
ive of accepting higher stent velocities based on the stent charac-
teristics, and in general, we know that there is a tendency of duplex
to overestimate stenosis. Therefore the chance of missing high-
grade asymptomatic lesions when applying similar criteria in an
accredited vascular laboratory is not likely.
